Canada (CA)

close-button

Types of publications

Journal article
Book chapter / Article in edited volumes
Authored book
Translation
Thesis
Edited Volume
Conference contribution
Other publication type
Unpublished / Preprint

Publication year

From
To

Abstract

Journal

High-Knee-Flexion Posture Recognition Using Multi-Dimensional Dynamic Time Warping on Inertial Sensor Data (2025) Laudanski AF, Küderle A, Kluge F, Eskofier B, Acker SM Journal article Change of the guards—Looking back at Michael Droller: Visionary and supporter—The perspective of the International Bladder Cancer Network (2025) Schmitz-Dräger B, Grossmann HB, Goebell P, Kamat AM, Black PC Journal article Effect of semaglutide on kidney function across different levels of baseline HbA1c, blood pressure, body weight and albuminuria in SUSTAIN 6 and PIONEER 6 (2025) Apperloo EM, Cherney DZ, Kuhlman AB, Mann JF, Rasmussen S, Rossing P, Tuttle KR, et al. Journal article S3-Leitlinie Diagnostik und Therapie biliärer Karzinome – Kurzversion (2025) Groβ S, Bitzer M, Albert J, Blödt S, Boda-Heggemann J, Borucki K, Brunner T, et al. Journal article On-chip microresonator dispersion engineering via segmented sidewall modulation (2025) Kheyri M, Zhang S, Bi T, Pal A, Zhang H, Zhang Y, Alabbadi A, et al. Journal article Mathematica program for numerically computing real and complex critical points in four-dimensional Lorentzian spinfoam amplitudes (2025) Han M, Liu H, Qu D Journal article A phase III trial of adjuvant ribociclib plus endocrine therapy versus endocrine therapy alone in patients with HR-positive/HER2-negative early breast cancer: final invasive disease-free survival results from the NATALEE trial (2025) Hortobagyi GN, Lacko A, Sohn J, Cruz F, Ruiz Borrego M, Manikhas A, Hee Park Y, et al. Journal article Heterozygous UBR5 variants result in a neurodevelopmental syndrome with developmental delay, autism, and intellectual disability (2025) Sabeh P, Dumas SA, Maios C, Daghar H, Korzeniowski M, Rousseau J, Lines M, et al. Journal article Efficacy and safety of deuruxolitinib, an oral selective Janus kinase 1/2 inhibitor, in adults with alopecia areata: Results from the THRIVE-AA2 Phase 3, randomized, double-blind, controlled trial (2025) Tsianakas A, Passeron T, Magnolo N, Blume-Peytavi U, Kelly V, Day I, Serrao R, et al. Journal article Dose threshold values for endovascular photodynamic therapy (PDT) in normal pig pancreas and human pancreatic cancer (2025) Saeidi T, Vazquez AG, Verde J, Wanert F, Spiridon IA, Schmid A, Swanstrom L, et al. Journal article